Taming three high-risk: Chemotherapy complications

Nursing

Volumn 41, Issue 11, 2011, Pages 30-37

  Held Warmkessel, Jeanne ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CHEMICALLY INDUCED DISORDER; ENTEROPATHY; FEVER; HUMAN; KIDNEY DISEASE; NEUTROPENIA; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH; REVIEW;

ANTINEOPLASTIC AGENTS; FEVER; HUMANS; INTESTINAL DISEASES; KIDNEY DISEASES; NEUTROPENIA; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH;

EID: 83055187971     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: 10.1097/01.NURSE.0000406191.88558.04     Document Type: Article

References (20)

1. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-e93
2. National Comprehensive Cancer Network. NCCN Practice Guidelines. Prevention and treatment of cancer-related infections (version 2.2009). 2009. http://www.nccn.org/professionals/physician-gls/pdf/infections.pdf.
3. Lee CS, Friese CR. Bacterial infections in patients with solid tumors. Oncology Nurse Edition. 2010;24(7):14-21.
4. Cameron D. Management of chemotherapyassociated febrile neutropenia. Br J Cancer. 2009; 101(suppl 1):S18-S22.
5. Antoniadou A, Giamarellou H. Fever of unknown origin in febrile leucopenia. Infect Dis Clin North Am. 2007;21(4):1055-1090. (Pubitemid 350166841)
6. O'Leary C. Neutropenia and infection. In: Brown CG, ed. Guide to Oncology Symptom Management. Pittsburgh, PA: Oncology Nursing Society; 2010.
7. Institute for Healthcare Improvement. How-to guide: prevent central line-associated bloodstream infection. http://www.ihi.org.
8. de Jonge MJ, Verweij J. Renal toxicities of chemotherapy. Semin Oncol. 2006;33(1):68-73. (Pubitemid 43214487)
9. Benoit DD, Hoste EA. Acute kidney injury in critically ill patients with cancer. Crit Care Clin. 2010;26(1):151-179.
10. Winkelman C. Assessment of the renal/urinary system. In: Ignatavicius DD, Workman ML, eds. Medical-Surgical Nursing. 6th ed. St. Louis, MO: Elsevier Saunders; 2010.
11. Lohr L. Chemotherapy-induced nausea and vomiting. Cancer J. 2008;14(2):85-93.
12. Hesketh PJ. Prevention and treatment of chemotherapy-induced nausea and vomiting. UpToDate. 2011. http://www.uptodate.com.
13. Coleman J. Diarrhea. In: Brown CG, ed. Guide to Oncology Symptom Management. Pittsburgh, PA: Oncology Nursing Society; 2010.
14. Brown C. Oral mucositis. In: Brown CG, ed. Guide to Oncology Symptom Management. Pittsburgh, PA: Oncology Nursing Society; 2010.
15. Tipton JM, McDaniel RW, Barbour L, et al. Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs. 2007;11(1):69-78.
16. Merchan JR. Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency. UpToDate. 2011. http://www.uptodate.com/ contents/chemotherapy-related-nephrotoxicity-and-dose-modification-in-patients- withrenal-insufficiency?source=search-result&selectedTitle=1-8.
17. Polovich M, Whitford JM, Olsen M. Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. 3rd ed. Pittsburgh, PA: Oncology Nursing Society; 2009.
18. Schrier RW, Edelstein CL. Acute kidney injury: pathogenesis, diagnosis, and management. In: Schrier RW, ed. Renal and Electrolyte Disorders. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.
19. Porth CM. Essentials of Pathophysiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.
20. Hesketh PJ. Pathophysiology and prediction of chemotherapy-induced nausea and vomiting. UpToDate. 2011. http://www.uptodate.com.